Karnataka: Govt Ayurveda Medical College Distributes Immunity Booster To 12,000 People
Mysuru - Government Ayurveda Medical College and Hospital Principal Dr Gajanana Hegde said that the College has distributed Ayurveda and Unani immunity boosters to more than 12,000 people.
Dr Hegde said that Samshamani Vati, an Ayurvedic drug made from Amrutha Balli, Araq Ajeeb, Unani drops and Draksha Avaleha, Ayurveda Chawanprash were distributed to the people.
Read Also: Cadila Pharma launches immunity booster syrup under brand name
Claiming that the AYUSH Department has distributed these medicines for free, he said that the number of people seeking the immunity boosters is increasing day by day.
Asserting that these medicines help in building immunity immensely, Dr Hegde said that the people must consume them twice a day. Developing immunity holds key for containing the spread of the deadly pandemic. Apart from having medicines, physical exercises and consumption of nutritious foods too is important for building one's immunity, he added.
Read Also: Kerala: Ayurveda doctors come out with music video to boost morale of Corona warriors
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!